In liver and pancreas cancer models, UTX can control the expression of negative regulators of mTOR such as DEPTOR, and its disruption prevents their transcription and facilitates tumorigenesis through increased mTORC1 activity (Revia et al., 2022). This evidence concerns the gene DEPTOR and pancreatic neoplasm.